Estrogen-induced genes, WISP-2 and pS2, respond divergently to protein kinase pathway

Biochemical and Biophysical Research Communications

Volumn 309, Issue 2, 2003, Pages 272-278

  Inadera, Hidekuni ^a,b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Estrogen receptor; MCF 7; Protein kinase; pS2; WISP 2

Indexed keywords

ANTIESTROGEN; CHOLERA TOXIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOHEXIMIDE; ESTRADIOL; ESTROGEN; FULVESTRANT; INTERLEUKIN 1ALPHA; ISOBUTYLMETHYLXANTHINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN PS2; PROTEIN SYNTHESIS INHIBITOR; PROTEIN WISP 2; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; PROTEIN EXPRESSION; REGULATORY MECHANISM; STIMULATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0041923939     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.07.001     Document Type: Article

References (46)

1. Tsai M.J., O'Malley B.W. Molecular mechanism of action of steroid/ thyroid receptor superfamily members. Annu. Rev. Biochem. 63:1994;451-486.
2. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P. The nuclear receptor superfamily: the second decade. Cell. 83:1995;835-839.
3. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., Gustafsson J.A. Mechanisms of estrogen action. Physiol. Rev. 81:2001;1535-1565.
4. Beato M. Gene regulation by steroid hormones. Cell. 56:1989;335-344.
5. Beato M., Herrlich P., Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell. 83:1995;851-857.
6. Weigel N.L., Zhang Y. Ligand-independent activation of steroid hormone receptors. J. Mol. Med. 76:1998;469-479.
7. Gottlicher M., Heck S., Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J. Mol. Med. 76:1998;480-489.
8. Cho H., Katzenellenbogen B.S. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Mol. Endocrinol. 7:1993;441-452.
9. Cho H., Aronica S.M., Katzenellenbogen B.S. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic AMP, estradiol, IGF-1 and serum factors. Endocrinology. 134:1994;658-664.
10. ′-monophosphate and ligands including antiestrogens Mol. Endocrinol. 8:1994;1397-1406.
11. Tzukerman M., Zhang X.K., Pfahl M. Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradeconylphorbol-13-acetate: a molecular analysis. Mol. Endocrinol. 5:1991;1983-1992.
12. Inadera H., Hashimoto S., Dong H.-Y., Suzuki T., Nagai S., Yamashita T., Toyoda N., Matsushima K. WISP-2 as a novel estrogen-responsive gene in human breast cancer cells. Biochem. Biophys. Res. Commun. 275:2000;108-114.
13. Inadera H., Dong H.-Y., Matsushima K. WISP-2 is a secreted protein and can be a marker of estrogen exposure in MCF-7 cells. Biochem. Biophys. Res. Commun. 294:2002;602-608.
14. Soule H.D., Vazguez J., Long A., Albert S., Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51:1973;1409-1416.
15. Inadera H., Sekiya T., Yoshimura T., Matsushima K. Molecular analysis of the inhibition of monocyte chemoattractant protein-1 gene expression by estrogens and xenoestrogens in MCF-7 cells. Endocrinology. 141:2000;50-59.
16. Darbre P., Yates J., Curtis S., King R.J.B. Effect of estradiol on human breast cancer cells in culture. Cancer Res. 43:1983;349-354.
17. Berthois Y., Katzenellenbogen J.A., Katzenellenbogen B.S. Phenol red in tissue culture is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. USA. 83:1986;2496-2500.
18. Brown A.M.C., Jeltsch J.-M., Roberts M., Chambon P. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc. Natl. Acad. Sci. USA. 81:1984;6344-6348.
19. ′-monophosphate in MCF-7 cells Endocrinology. 133:1993;571-576.
20. Nishizuka Y. Studies and perspectives of protein kinase C. Science. 233:1986;305-312.
21. Nishizuka Y. Protein kinases. 5. Protein kinase C and lipid signaling for sustained cellular-responses. FASEB J. 9:1995;484-496.
22. Darbon J.M., Valette A., Bayard F. Phorbol esters inhibit the proliferation on MCF-7 cells - possible implication of protein kinase C. Biochem. Pharmacol. 35:1986;2683-2686.
23. Valette A., Gas N., Jozan S., Roubinit F., Dupont M.A., Bayard F. Influence of 12-O-tetradeconylphorbol-13-acetate on proliferation and maturation of human breast carcinoma cells (MCF-7): relationship to cell cycle events. Cancer Res. 47:1987;1615-1620.
24. Guilbaud N., Pichon M.F., Faye J.C., Bayard F., Valette A. Modulation of estrogen receptors by phorbol esters in human breast MCF-7 cell line. Mol. Cell. Endocrinol. 56:1988;157-163.
25. Carroll J.S., Prall O.W., Musgrove E.A., Sutherland R.L. A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence. J. Biol. Chem. 275:2000;38221-38229.
26. WAF1/Cip1. J. Biol. Chem. 276:2001;25823-25833.
27. Paciotti G.F., Tamarkin T. Interleukin-1 directly regulates hormone-dependent human breast cancer cell proliferation in vitro. Mol. Endocrinol. 2:1988;459-464.
28. Danforth D.N. Jr., Sgagias M.K. Interleukin 1α blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitro. Cancer Res. 51:1991;1488-1493.
29. Aronica S.M., Katzenellenbogen B.S. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol. Endocrinol. 7:1993;723-732.
30. Le Goff P., Montano M.M., Schodin D.J., Katzenellenbogen B.S. Phosphorylation of the human receptor - identification of hormone-regulated sites and examination of their influence on transcriptional activity. J. Biol. Chem. 269:1994;4458-4466.
31. Aronica S.M., Katzenellenbogen B.S. Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3', 5'-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors. Endocrinology. 128:1991;2045-2052.
32. Martin M.B., Garcia-Morales P., Stoica A., Solomon H.B., Pierces M., Katz D., Zhang S., Danielsent M., Saceda M. Effects of 12-O-tetradecanoylphorbol-13-acetate on estrogen receptor activity in MCF-7 cells. J. Biol. Chem. 270:1995;25244-25251.
33. Sgagias M.K., Kasid A., Danforth D.N. Interleukin-1α and tumor necrosis factor-α inhibit growth and induce TNF messenger RNA in MCF-7 human breast cancer cells. Mol. Endocrinol. 5:1991;1740-1747.
34. Yee D. Can the insulin-like growth-factors regulate breast-cancer growth? Breast Cancer Res. Tr. 22:1992;3-5.
35. Lee A.V., Yee D. Insulin-like growth factors and breast cancer. Biomed. Pharmacother. 49:1995;415-421.
36. Lee A.V., Weng C.-N., Jackson J.G., Yee D. Activation of estrogen receptor-mediated gene transcription by IGF-1 in human breast cancer cells. J. Endocrinol. 152:1997;39-47.
37. Pennica D., Swanson T.A., Welsh J.W., Roy M.A., Lawrence D.A., Lee J., Brush J., Taneyhill L.A., Deuel B., Lew M., Watanabe C., Cohen R.L., Melhem M.F., Finley G.G., Quirke P., Goddard A.D., Hillan K.J., Gurney A.L., Botstein D., Levine A.J. WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. USA. 95:1998;14717-14722.
38. Lau L.F., Lam S.C.T. The family of CCN angiogenic regulators: the integrin connection. Exp. Cell Res. 248:1999;44-57.
39. Brigtock D.R. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr. Rev. 20:1999;189-206.
40. 1 transition of cultured mouse cells. EMBO J. 4:1985;3145-3151.
41. Lau L.F., Nathans D. Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. Proc. Natl. Acad. Sci. USA. 84:1987;1182-1186.
42. Almendral J.M., Sommer D., Macdonaldbravo H., Burckhardt J., Perera J., Bravo R. Complexity of the early genetic response to growth-factors in mouse fibroblasts. Mol. Cell Biol. 8:1988;2140-2148.
43. Delmolino L.M., Stearns N.A., Castellot J.J. COP-1, a member of the CCN family, is a heparin-induced growth arrest specific gene in vascular smooth muscle cells. J. Cell Physiol. 188:2001;45-55.
44. Zhang R., Averboukh L., Zhu W., Zhang H., Jo H., Dempsey P.J., Coffey R.J., Pardee A.B., Liang P. Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation. Mol. Cell Biol. 18:1998;6131-6141.
45. O'Brian C., Vogel V.C., Singletary S.E., Ward N.E. Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res. 49:1989;3215-3217.
46. Tonetti D.A., Morrow M., Kidwai N., Gupta A., Badve S. Elevated protein kinase C alpha expression may be predictive of tamoxifen treatment failure. Br. J. Cancer. 88:2003;1400-1402.